Glaukos Corp (GKOS)

Exchange
NYSE
Symbol
GKOS
Sector
Life Sciences
Industry
Surgical & Medical Instruments & Apparatus
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    133.74
  • High
    142.45
  • Low
    130.91
  • Close
    140.64
  • Volume
    1,428,630

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
7.49
Receivables turnover
7.61
Payables turnover
23.40
Working capital turnover
0.94
Days of inventory on hand (DOH)
48.72
Days of sales outstanding (DSO)
47.97
Number of days of payables
15.60
Fixed asset turnover
2.94
Total asset turnover
0.32
 Liquidity ratios
Current ratio
5.34
Quick ratio
4.53
Cash ratio
3.99
Cash conversion cycle
81.10
 Solvency ratios
Debt-to-assets ratio
0.30
Debt-to-capital ratio
0.38
Debt-to-equity ratio
0.61
Financial leverage ratio
2.04
Interest coverage
-8.81
 Profitability ratios
Gross profit margin
78.86%
Operating profit margin
-42.44%
Pretax margin
-44.11%
Net profit margin
-44.41%
Operating return on assets (Operating ROA)
-13.69%
Return on assets (ROA)
-14.32%
Return on total capital
-16.13%
Return on equity (ROE)
-29.16%